#BEGIN_DRUGCARD DB02527

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
60-92-4

# ChEBI_ID:
17489

# Chemical_Formula:
C10H12N5O6P

# Chemical_IUPAC_Name:
(4aR,6S,7S,7aR)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-1,3,5,2$l^{5}-furo[3,2-d][1,3,2$l^{5}]dioxaphosphinin-2-one

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Cyclic adenosine monophosphate (cAMP, cyclic AMP or 3'-5'-cyclic adenosine monophosphate) is a molecule that is important in many biological processes; it is derived from adenosine triphosphate (ATP).

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
-2.96

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Cyclic Adenosine Monophosphate

# HET_ID:
CMP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6+,7+,10+/m1/s1

# InChI_Key:
InChIKey=IVOMOUWHDPKRLL-ASCDQALMSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00575

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2527

# Mechanism_Of_Action:
Not Available

# Melting_Point:
219-220 Â°C

# Molecular_Weight_Avg:
329.2059

# Molecular_Weight_Mono:
329.052519653

# Organisms_Affected:
Humans and other mammals

# PDB_Experimental_ID:
1I6X

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.3

# Predicted_LogS:
-2

# Predicted_Water_Solubility:
3.58e+00 g/l

# Primary_Accession_No:
DB02527

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
25322948

# PubChem_Substance_ID:
46508991

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00959

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC=NC2=C1N=CN2[C@H]1O[C@@H]2CO[P@](O)(=O)O[C@@H]2[C@@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
3',5'-Cyclic AMP
3'-5'-cyclic adenosine monophosphate
Cyclic AMP
Cyclic adenylic acid
cAMP

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:13 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Cyclic_adenosine_monophosphate

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
HCN2

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
Not Available

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
7141

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
Not Available

# Drug_Target_1_Name:
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2

# Drug_Target_1_Number_of_Residues:
0

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
Not Available

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
Not Available

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q9UL51

# Drug_Target_1_SwissProt_Name:
HCN2_HUMAN

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
Not Available

# Drug_Target_1_Transmembrane_Regions:
Not Available

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
PRKAR1A

# Drug_Target_2_GenBank_ID_Gene:
M18468

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
PRKAR1A

# Drug_Target_2_Gene_Sequence:
>1146 bp
ATGGAGTCTGGCAGTACCGCCGCCAGTGAGGAGGCACGCAGCCTTCGAGAATGTGAGCTC
TACGTCCAGAAGCATAACATTCAAGCGCTGCTCAAAGATTCTATTGTGCAGTTGTGCACT
GCTCGACCTGAGAGACCCATGGCATTCCTCAGGGAATACTTTGAGAGGTTGGAGAAGGAG
GAGGCAAAACAGATTCAGAATCTGCAGAAAGCAGGCACTCGTACAGACTCAAGGGAGGAT
GAGATTTCTCCTCCTCCACCCAACCCAGTGGTTAAAGGTAGGAGGCGACGAGGTGCTATC
AGCGCTGAGGTCTACACGGAGGAAGATGCGGCATCCTATGTTAGAAAGGTTATACCAAAA
GATTACAAGACAATGGCCGCTTTAGCCAAAGCCATTGAAAAGAATGTGCTGTTTTCACAT
CTTGATGATAATGAGAGAAGTGATATTTTTGATGCCATGTTTTCGGTCTCCTTTATCGCA
GGAGAGACTGTGATTCAGCAAGGTGATGAAGGGGATAACTTCTATGTGATTGATCAAGGA
GAGACGGATGTCTATGTTAACAATGAATGGGCAACCAGTGTTGGGGAAGGAGGGAGCTTT
GGAGAACTTGCTTTGATTTATGGAACACCGAGAGCAGCCACTGTCAAAGCAAAGACAAAT
GTGAAATTGTGGGGCATCGACCGAGACAGCTATAGAAGAATCCTCATGGGAAGCACACTG
AGAAAGCGGAAGATGTATGAGGAATTCCTTAGTAAAGTCTCTATTTTAGAGTCTCTGGAC
AAGTGGGAACGTCTTACGGTAGCTGATGCATTGGAACCAGTGCAGTTTGAAGATGGGCAG
AAGATTGTGGTGCAGGGAGAACCAGGGGATGAGTTCTTCATTATTTTAGAGGGGTCAGCT
GCTGTGCTACAACGTCGGTCAGAAAATGAAGAGTTTGTTGAAGTGGGAAGATTGGGGCCT
TCTGATTATTTTGGTGAAATTGCACTACTGATGAATCGTCCTCGTGCTGCCACAGTTGTT
GCTCGTGGCCCCTTGAAGTGCGTTAAGCTGGACCGACCTAGATTTGAACGTGTTCTTGGC
CCATGCTCAGACATCCTCAAACGAAACATCCAGCAGTACAACAGTTTTGTGTCACTGTCT
GTCTGA

# Drug_Target_2_General_Function:
Involved in cAMP-dependent protein kinase regulator activity

# Drug_Target_2_General_References:
12665801	Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31.
1889088	Jones KW, Shapero MH, Chevrette M, Fournier RE: Subtractive hybridization cloning of a tissue-specific extinguisher: TSE1 encodes a regulatory subunit of protein kinase A. Cell. 1991 Sep 6;66(5):861-72.
2310396	Sandberg M, Skalhegg B, Jahnsen T: The two mRNA forms for the type I alpha regulatory subunit of cAMP-dependent protein kinase from human testis are due to the use of different polyadenylation site signals. Biochem Biophys Res Commun. 1990 Feb 28;167(1):323-30.
3426618	Sandberg M, Tasken K, Oyen O, Hansson V, Jahnsen T: Molecular cloning, cDNA structure and deduced amino acid sequence for a type I regulatory subunit of cAMP-dependent protein kinase from human testis. Biochem Biophys Res Commun. 1987 Dec 31;149(3):939-45.
8977401	Solberg R, Sandberg M, Natarajan V, Torjesen PA, Hansson V, Jahnsen T, Tasken K: The human gene for the regulatory subunit RI alpha of cyclic adenosine 3', 5'-monophosphate-dependent protein kinase: two distinct promoters provide differential regulation of alternately spliced messenger ribonucleic acids. Endocrinology. 1997 Jan;138(1):169-81.

# Drug_Target_2_HGNC_ID:
HGNC:9388

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
5849

# Drug_Target_2_Locus:
17q23-q24

# Drug_Target_2_Molecular_Weight:
42982

# Drug_Target_2_Name:
cAMP-dependent protein kinase type I-alpha regulatory subunit

# Drug_Target_2_Number_of_Residues:
381

# Drug_Target_2_PDB_ID:
1RL3

# Drug_Target_2_Pathway:
Acebutolol Pathway	SMP00296
Alprenolol Pathway	SMP00297
Atenolol Pathway	SMP00298
Betaxolol Pathway	SMP00299
Bisoprolol Pathway	SMP00300
Carvedilol Pathway	SMP00367
Citalopram Pathway	SMP00424
Desipramine Pathway	SMP00423
Escitalopram Pathway	SMP00425
Esmolol Pathway	SMP00301
Fluoxetine Pathway	SMP00426
Imipramine Pathway	SMP00422
Labetalol Pathway	SMP00368
Metoprolol Pathway	SMP00302
Nadolol Pathway	SMP00303
Nebivolol Pathway	SMP00366
Oxprenolol Pathway	SMP00304
Penbutolol Pathway	SMP00305
Pindolol Pathway	SMP00306
Propranolol Pathway	SMP00307

# Drug_Target_2_Pfam_Domain_Function:
PF00027	cNMP_binding
PF02197	RIIa

# Drug_Target_2_Protein_Sequence:
>cAMP-dependent protein kinase type I-alpha regulatory subunit
MESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKE
EAKQIQNLQKAGTRTDSREDEISPPPPNPVVKGRRRRGAISAEVYTEEDAASYVRKVIPK
DYKTMAALAKAIEKNVLFSHLDDNERSDIFDAMFSVSFIAGETVIQQGDEGDNFYVIDQG
ETDVYVNNEWATSVGEGGSFGELALIYGTPRAATVKAKTNVKLWGIDRDSYRRILMGSTL
RKRKMYEEFLSKVSILESLDKWERLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSA
AVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPRAATVVARGPLKCVKLDRPRFERVLG
PCSDILKRNIQQYNSFVSLSV

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
P10644

# Drug_Target_2_SwissProt_Name:
KAP0_HUMAN

# Drug_Target_2_Synonyms:
TSE1
Tissue- specific extinguisher 1

# Drug_Target_2_Theoretical_pI:
5.00

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
Not Available

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
PRKAR2B

# Drug_Target_3_Gene_Sequence:
Not Available

# Drug_Target_3_General_Function:
Not Available

# Drug_Target_3_General_References:
Not Available

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
7007

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
Not Available

# Drug_Target_3_Name:
cAMP-dependent protein kinase type II-beta regulatory subunit

# Drug_Target_3_Number_of_Residues:
0

# Drug_Target_3_PDB_ID:
Not Available

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
Not Available

# Drug_Target_3_Protein_Sequence:
Not Available

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
Not Available

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
P31323

# Drug_Target_3_SwissProt_Name:
KAP3_HUMAN

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
Not Available

# Drug_Target_3_Transmembrane_Regions:
Not Available

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
D89624

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
cyaB2

# Drug_Target_4_Gene_Sequence:
>2583 bp
ATGTCATTGCAACAGCGTAATTTTGGGGAGACTGGCGATTTGATCTTAGGTACGCAAAAC
CAAGAGCAAAACTTGCCAGAAACTTCGGCTCCTGTCGGCACACTAGCCCGCAGAAAAGGT
ACTATTTCGACATTTCTTGCTCCCTTAACTCAGGATACTTTTAAACAAGTTGTTACAGAA
GTCGAGCAAAAACTCCAAATTGTGCATCAAACCCTGTCAATGTTGGATTCTCACGGGTTT
GAAAATATCCTGCAAGAGATGTTGCAGTCAATTACCTTAAAAACTGGGGAATTGTTGGGG
GCAGATCGGACGACTATATTTTTGCTAGATGAAGAAAAACAAGAATTGTGGTCGATTGTC
GCCGCCGGAGAAGGCGATCGCTCCCTAGAAATTCGCATCCCCGCCGACAAGGGGATTGCC
GGTGAAGTCGCTACTTTTAAACAAGTAGTTAATATACCCTTTGACTTTTATCACGATCCT
CGGTCGATATTTGCCCAAAAACAAGAGAAAATCACTGGCTACCGCACATATACAATGCTG
GCTTTACCGCTATTGAGTGAGCAAGGGCGATTAGTCGCGGTGGTACAGTTACTCAACAAA
TTAAAACCTTACAGTCCTCCTGATGCACTGCTAGCAGAACGGATTGATAATCAAGGTTTT
ACCAGTGCAGATGAGCAATTGTTTCAAGAATTTGCGCCCTCAATTCGCTTGATTTTGGAG
TCGTCACGCTCCTTTTATATAGCGACGCAAAAACAAAGGGCGGCGGCGGCGATGATGAAG
GCGGTAAAGTCTCTGAGCCAAAGTAGTCTGGATTTAGAAGATACCCTCAAACGGGTAATG
GATGAAGCCAAGGAACTGATGAACGCCGATCGCAGTACCTTATGGCTGATAGACCGCGAT
CGCCATGAATTATGGACGAAAATTACTCAAGATAATGGTTCTACTAAGGAGTTGCGCGTT
CCCATAGGTAAAGGTTTTGCCGGGATCGTCGCCGCATCCGGTCAAAAACTCAACATCCCT
TTTGATTTATACGACCATCCAGACTCGGCAACTGCCAAACAAATCGACCAGCAAAATGGC
TACCGCACCTGTAGTTTATTATGTATGCCTGTATTTAACGGCGACCAAGAATTAATTGGT
GTGACCCAACTGGTAAATAAAAAGAAAACCGGAGAGTTCCCCCCCTATAATCCAGAAACT
TGGCCGATAGCGCCCGAATGCTTCCAAGCGAGTTTTGACCGCAACGACGAAGAATTCATG
GAAGCTTTTAATATTCAAGCCGGGGTGGCTTTACAAAATGCTCAGTTGTTTGCCACAGTC
AAGCAACAAGAGCAAATGCAACGGGATATTCTGCGGAGTTTGTCCAACGGTGTGATTTCC
ACAGATAAGTCTGGGACAATTATTGCAGCGAATGAAAGCGCCCAGCGTTTGTTGGGGCTG
GAATCAGAAGATCGTTTGGAAGGTAAACTCATCAGTGAGGCGATCGCCATTAAAGAAGGC
GATTTTAGCAAATGGTGTCAAGATGCCTTACATGGGACAGACCTCAAAGGCCGCCAGCAA
TATTACCCAGACCGCACACTAGTAAGCACTGAAGCAGCACAAAATAGCATTAACCTATCG
ATTAATACCATTGCCGATGCTAGCGATCCCCAGCAAGTCTGCGGCGCGTTGGTGGTGATG
GAAGATATTAGCGATGAGAAGCGCCTCAAGAGTACGATGTATCGCTACATGACTCAGGAA
TTAGCCGAGGAATTGCTGAAATTAGACGATGCTAAACTGGGAGGCGATCGCAAAGAAGTT
TCCATCCTCTTTTCGGATATTCGCGGTTACACCACTTTGACGGAAAATCTGGAAGCCGAA
GAAGTCGTAAGTATGCTCAATGAATATTTTGAGTCGATGGTAGAGGCTGTATTCAAACAC
AAAGGCACTCTGGATAAATACATCGGTGATGCGATTATGGCCGTGTTTGGTTCACCTTTG
CCCTTAGAAGAACACGCTTGGATGGCTGTAAAAACATCTATAGAAATGCGTCATCGCTTA
CAAGAATTTAATCAAAAACGTTATGCAGCTAATAAACCCCGAATCAATATCGGTATTGGC
ATCAATTCCGACACCGTAATTAGTGGCAACATTGGCTCTAGTAAACGTATGGAATTTACA
GCTATTGGTGATGGTGTGAATCTGGGTTCCCGCTTAGAAAGTGTGAGTAAGCAGTATGGT
TGCGACATTATTCTCAGTGATAATACTTTTAAACCATGCCAGGAAAATATTTGGGCTAGA
GAACTAGATTTTATCCGTGTTAAAGGCAGAAATGAGCCAGTATCTATATACGAGTTAATT
GGTTTACGTTCTGTCCCCATTGCTAGTGAAAAATTGCAGGTAATTGAGCATTATCACAAG
GGACGGGAATATTACCTGCAACGTCAATTTTCCTTAGCAAGAGCAGAATTTGCCAATGTT
TTAGCAGTTGATAAACATGACAAAGCCGCGATGTTGCATCTGCTACGCTGTCAGCATTGG
TTACAATCACCTCCAACAGATTCAGAATGGGATGAAGGGGTGTGGACGTTTCAGGAGAAG
TGA

# Drug_Target_4_General_Function:
Involved in phosphorus-oxygen lyase activity

# Drug_Target_4_General_References:
9171404	Katayama M, Ohmori M: Isolation and characterization of multiple adenylate cyclase genes from the cyanobacterium Anabaena sp. strain PCC 7120. J Bacteriol. 1997 Jun;179(11):3588-93.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
4759

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
96776

# Drug_Target_4_Name:
Adenylate cyclase

# Drug_Target_4_Number_of_Residues:
860

# Drug_Target_4_PDB_ID:
1YKD

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00211	Guanylate_cyc
PF00989	PAS
PF01590	GAF

# Drug_Target_4_Protein_Sequence:
>Adenylate cyclase
MSLQQRNFGETGDLILGTQNQEQNLPETSAPVGTLARRKGTISTFLAPLTQDTFKQVVTE
VEQKLQIVHQTLSMLDSHGFENILQEMLQSITLKTGELLGADRTTIFLLDEEKQELWSIV
AAGEGDRSLEIRIPADKGIAGEVATFKQVVNIPFDFYHDPRSIFAQKQEKITGYRTYTML
ALPLLSEQGRLVAVVQLLNKLKPYSPPDALLAERIDNQGFTSADEQLFQEFAPSIRLILE
SSRSFYIATQKQRAAAAMMKAVKSLSQSSLDLEDTLKRVMDEAKELMNADRSTLWLIDRD
RHELWTKITQDNGSTKELRVPIGKGFAGIVAASGQKLNIPFDLYDHPDSATAKQIDQQNG
YRTCSLLCMPVFNGDQELIGVTQLVNKKKTGEFPPYNPETWPIAPECFQASFDRNDEEFM
EAFNIQAGVALQNAQLFATVKQQEQMQRDILRSLSNGVISTDKSGTIIAANESAQRLLGL
ESEDRLEGKLISEAIAIKEGDFSKWCQDALHGTDLKGRQQYYPDRTLVSTEAAQNSINLS
INTIADASDPQQVCGALVVMEDISDEKRLKSTMYRYMTQELAEELLKLDDAKLGGDRKEV
SILFSDIRGYTTLTENLEAEEVVSMLNEYFESMVEAVFKHKGTLDKYIGDAIMAVFGSPL
PLEEHAWMAVKTSIEMRHRLQEFNQKRYAANKPRINIGIGINSDTVISGNIGSSKRMEFT
AIGDGVNLGSRLESVSKQYGCDIILSDNTFKPCQENIWARELDFIRVKGRNEPVSIYELI
GLRSVPIASEKLQVIEHYHKGREYYLQRQFSLARAEFANVLAVDKHDKAAMLHLLRCQHW
LQSPPTDSEWDEGVWTFQEK

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
P94182

# Drug_Target_4_SwissProt_Name:
P94182_9NOST

# Drug_Target_4_Synonyms:
EC 4.6.1.1

# Drug_Target_4_Theoretical_pI:
4.90

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
BA000012

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
mll3241

# Drug_Target_5_Gene_Sequence:
>1068 bp
TCAAGCGCTCGCCGCAGCGCCGCGACGCTCGAGCGCGGTCTTGCGGAAGATTTCCGCGAT
CTCCGGGCTGCTGCTGCACAACATCTGGAAATCCGCCGAATGCAGCGACAGGAGTGAGAC
CGTCGTTGCGGCGCTGACGGTCGCCGAACGCGGTTCGCCGCTGATCAGCGCCATCTCGCC
GAAGAAGGCGCCAGGGCCAAGCTCCACCGGATTCGGCGTCGCGACGCTGACGCTCCCCTC
CACGACGAAGAACATCCGATCGCCGGGCTCGCCAATGCGGCAGATCACGGCGCCCGCCGG
CACCGTGCGGGCTCTTAAGGCGCGCACGATCTCGACCAGCACGGCCGGGCCGAGCTTCTG
AAACAACGGCACGGCGGCGACCAATTGCCAATTGCGGACGAAATCCCCGCGACGGACTTC
TTGATAGAAGCCTGTGGCAAGAATGCCGGCCCAGAGTCCGAAGATGCCGATGCCACTCAT
CATGACCGCCCCGGCAAGGACGCGGCCGGCGAAGCTTTGCGGGATAGTGTCCCCATAGCC
GGTGGTGGACAGCGTGACCACCGCCCACCACATTGCCTGGGGAATGCTGCCGAACTTTTC
CGGTTGGATATCGCGCTCGATGACATAGGCTGCGAGCGCCACTGCGAACAGAACGACGCC
GAAGAGCGTGGTGACGCCGATCAGATTGCGTGCTTCGTTGGCCAGGACCCTGCCCAGGAC
CGGGAAGAAAGTCGAGTCGCGCAGCGGTTTCAGCAGCCAGACAGCACAGTAGAGGCTCCA
GTCAGGCGAGCCGTCGAGCAGAAATGCGGCGAGTGGAACCAAGACTGCGAGCACATCGAT
GGCGATTTTGGGCGTCCTGTCCCGTACGACTCCCGCCCGGCGCTTGAGCAGCGTCGCGGC
CAGTTGCAGGAGATAGGCGCCCCAGATGACAGCGAGCAGGGCAGCCAGAGCCAGTCTGCT
TCGTCCGGACATGTCCGGTATCGTGAGCGCAGCCACCGCCAGCAACCCAGGCGCAGCCAG
CACCGCGTTGAGCGGCGCGTAAATTCTTAAGAAAGGCAGTACCGACAT

# Drug_Target_5_General_Function:
Involved in cAMP-dependent protein kinase regulator activity

# Drug_Target_5_General_References:
11214968	Kaneko T, Nakamura Y, Sato S, Asamizu E, Kato T, Sasamoto S, Watanabe A, Idesawa K, Ishikawa A, Kawashima K, Kimura T, Kishida Y, Kiyokawa C, Kohara M, Matsumoto M, Matsuno A, Mochizuki Y, Nakayama S, Nakazaki N, Shimpo S, Sugimoto M, Takeuchi C, Yamada M, Tabata S: Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res. 2000 Dec 31;7(6):331-8.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
4760

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
37736

# Drug_Target_5_Name:
Mll3241 protein

# Drug_Target_5_Number_of_Residues:
355

# Drug_Target_5_PDB_ID:
1VP6

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00027	cNMP_binding
PF07885	Ion_trans_2

# Drug_Target_5_Protein_Sequence:
>Mll3241 protein
MSVLPFLRIYAPLNAVLAAPGLLAVAALTIPDMSGRSRLALAALLAVIWGAYLLQLAATL
LKRRAGVVRDRTPKIAIDVLAVLVPLAAFLLDGSPDWSLYCAVWLLKPLRDSTFFPVLGR
VLANEARNLIGVTTLFGVVLFAVALAAYVIERDIQPEKFGSIPQAMWWAVVTLSTTGYGD
TIPQSFAGRVLAGAVMMSGIGIFGLWAGILATGFYQEVRRGDFVRNWQLVAAVPLFQKLG
PAVLVEIVRALRARTVPAGAVICRIGEPGDRMFFVVEGSVSVATPNPVELGPGAFFGEMA
LISGEPRSATVSAATTVSLLSLHSADFQMLCSSSPEIAEIFRKTALERRGAAASA

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
Q98GN8

# Drug_Target_5_SwissProt_Name:
CNGK1_RHILO

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
9.71

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasmic

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
J01598

# Drug_Target_6_GenBank_ID_Protein:
145594

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
crp

# Drug_Target_6_Gene_Sequence:
>633 bp
ATGGTGCTTGGCAAACCGCAAACAGACCCGACTCTCGAATGGTTCTTGTCTCATTGCCAC
ATTCATAAGTACCCATCCAAGAGCACGCTTATTCACCAGGGTGAAAAAGCGGAAACGCTG
TACTACATCGTTAAAGGCTCTGTGGCAGTGCTGATCAAAGACGAAGAGGGTAAAGAAATG
ATCCTCTCCTATCTGAATCAGGGTGATTTTATTGGCGAACTGGGCCTGTTTGAAGAGGGC
CAGGAACGTAGCGCATGGGTACGTGCGAAAACCGCCTGTGAAGTGGCTGAAATTTCGTAC
AAAAAATTTCGCCAATTGATTCAGGTAAACCCGGACATTCTGATGCGTTTGTCTGCACAG
ATGGCGCGTCGTCTGCAAGTCACTTCAGAGAAAGTGGGCAACCTGGCGTTCCTCGACGTG
ACGGGCCGCATTGCACAGACTCTGCTGAATCTGGCAAAACAACCAGACGCTATGACTCAC
CCGGACGGTATGCAAATCAAAATTACCCGTCAGGAAATTGGTCAGATTGTCGGCTGTTCT
CGTGAAACCGTGGGACGCATTCTGAAGATGCTGGAAGATCAGAACCTGATCTCCGCACAC
GGTAAAACCATCGTCGTTTACGGCACTCGTTAA

# Drug_Target_6_General_Function:
Signal transduction mechanisms

# Drug_Target_6_General_References:
11124031	Passner JM, Schultz SC, Steitz TA: Modeling the cAMP-induced allosteric transition using the crystal structure of CAP-cAMP at 2.1 A resolution. J Mol Biol. 2000 Dec 15;304(5):847-59.
1653449	Schultz SC, Shields GC, Steitz TA: Crystal structure of a CAP-DNA complex: the DNA is bent by 90 degrees. Science. 1991 Aug 30;253(5023):1001-7.
2828639	Weber IT, Steitz TA: Structure of a complex of catabolite gene activator protein and cyclic AMP refined at 2.5 A resolution. J Mol Biol. 1987 Nov 20;198(2):311-26.
2845936	Gronenborn AM, Sandulache R, Gartner S, Clore GM: Mutations in the cyclic AMP binding site of the cyclic AMP receptor protein of Escherichia coli. Biochem J. 1988 Aug 1;253(3):801-7.
3333845	Gent ME, Gartner S, Gronenborn AM, Sandulache R, Clore GM: Site-directed mutants of the cAMP receptor protein--DNA binding of five mutant proteins. Protein Eng. 1987 Jun;1(3):201-3.
6280140	Aiba H, Fujimoto S, Ozaki N: Molecular cloning and nucleotide sequencing of the gene for E. coli cAMP receptor protein. Nucleic Acids Res. 1982 Feb 25;10(4):1345-61.
6280141	Cossart P, Gicquel-Sanzey B: Cloning and sequence of the crp gene of Escherichia coli K 12. Nucleic Acids Res. 1982 Feb 25;10(4):1363-78.
6286624	McKay DB, Weber IT, Steitz TA: Structure of catabolite gene activator protein at 2.9-A resolution. Incorporation of amino acid sequence and interactions with cyclic AMP. J Biol Chem. 1982 Aug 25;257(16):9518-24.
8394684	Kolb A, Busby S, Buc H, Garges S, Adhya S: Transcriptional regulation by cAMP and its receptor protein. Annu Rev Biochem. 1993;62:749-95.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
3685

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
23641

# Drug_Target_6_Name:
Catabolite gene activator

# Drug_Target_6_Number_of_Residues:
210

# Drug_Target_6_PDB_ID:
1G6N

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00027	cNMP_binding
PF00325	Crp

# Drug_Target_6_Protein_Sequence:
>Catabolite gene activator
MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEM
ILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQ
MARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCS
RETVGRILKMLEDQNLISAHGKTIVVYGTR

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
This protein complexes with cyclic AMP and binds to specific DNA sites near the promoter to regulate the transcription of several catabolite-sensitive operons. The protein induces a severe bend in the DNA. Acts as a negative regulator of its own synthesis

# Drug_Target_6_SwissProt_ID:
P0ACJ8

# Drug_Target_6_SwissProt_Name:
CRP_ECOLI

# Drug_Target_6_Synonyms:
cAMP receptor protein
cAMP-regulatory protein

# Drug_Target_6_Theoretical_pI:
8.46

# Drug_Target_6_Transmembrane_Regions:
None

#END_DRUGCARD DB02527
